Compare GALT & AEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GALT | AEC |
|---|---|---|
| Founded | 2000 | 1989 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 199.2M | 165.3M |
| IPO Year | 2008 | N/A |
| Metric | GALT | AEC |
|---|---|---|
| Price | $2.46 | $5.67 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 307.8K | 42.5K |
| Earning Date | 05-14-2026 | 05-01-2015 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.22 | $4.42 |
| 52 Week High | $7.13 | $12.49 |
| Indicator | GALT | AEC |
|---|---|---|
| Relative Strength Index (RSI) | 43.01 | 49.23 |
| Support Level | $2.13 | $5.50 |
| Resistance Level | $3.32 | $6.04 |
| Average True Range (ATR) | 0.22 | 0.46 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 33.33 | 69.09 |
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Anfield Energy Inc is a mineral exploration and development company. This company focuses on uranium and vanadium development and near-term production. The exploration project of the company includes Shootaring Canyon Mill and Velvet-Wood and Slick Rock Uranium Project from Uranium One. The company's geographical segments are Canada and the United States.